Decoy Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Decoy Therapeutics Inc. (DCOY) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $4.10 per share as of 2019-06-30, per its 10-Q filed 2019-07-17.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2019-07-17
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.10.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.10.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.10.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.28.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2019-06-30 | $4.10 10-Q · filed 2019-07-17 |
| 2019-03-31 | $4.10 10-Q · filed 2019-05-01 |
| 2018-12-31 | $4.10 10-K · filed 2019-03-06 |
| 2018-09-30 | $4.28 10-Q · filed 2018-11-05 |
| 2018-06-30 | $4.86 10-Q · filed 2018-08-01 |
| 2018-03-31 | $5.78 10-Q · filed 2018-05-02 |
| 2017-12-31 | $6.65 10-K · filed 2018-03-07 |
| 2017-09-30 | $6.87 10-Q · filed 2017-11-06 |
| 2017-06-30 | $7.24 10-Q · filed 2017-08-02 |
| 2017-03-31 | $7.68 10-Q · filed 2017-05-03 |
| 2016-12-31 | $8.64 10-K · filed 2017-03-08 |
| 2016-09-30 | $8.69 10-Q · filed 2016-11-02 |
| 2016-06-30 | $8.55 10-Q · filed 2016-08-03 |
| 2016-03-31 | $8.35 10-Q · filed 2016-05-04 |
| 2015-12-31 | $8.05 10-K · filed 2016-03-08 |
| 2015-09-30 | $7.35 10-Q · filed 2015-11-04 |
| 2015-06-30 | $7.38 10-Q · filed 2015-08-05 |
| 2015-03-31 | $5.37 10-Q · filed 2015-05-06 |
| 2014-12-31 | $3.39 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |